Full name
LABORATORIUM SYMBIOSIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
LABORATORIUM SYMBIOSIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RUBIEŻ 46 / BUD.H, 61-612 POZNAŃ
TAX ID9721321733
Rate company:
LABORATORIUM SYMBIOSIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9721321733
KRS0000924312
Share capital5,000.00 zł
address
UL. RUBIEŻ 46 / BUD.H, 61-612 POZNAŃ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9721321733
REGON
520317438
KRS
0000924312
Legal form
limited liability company
Register Address
UL. RUBIEŻ 46 / BUD.H, 61-612 POZNAŃ
Date of registration in KRS
2021-10-29
Date of commencement of economic activity
2021-10-29
Act signature
PO.VIII NS-REJ.KRS/42327/24/936
Pkd codes
20.42.Z - Manufacture of cosmetics and toilet preparations
01.28.Z - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
20.13 - Manufacture of other inorganic basic chemicals
20.5 - Manufacture of other chemical products
21.10 - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.75.Z - Wholesale trade
72 - Scientific research and development activities
Payer VAT status
Active
Vat list bank account(s)
PL52 1600 1404 1803 3157 5000 0001 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2022 | 2023 | ||
|---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss)  | -41,3 | -66,8 | -61,7 |
EBITDA | -39,1 | -41,1 | -5,3 |
Short time liabilities | 47,9 | 164,5 | 243,3 |
Equity capital | -36,3 | -103 | -184 |
Operating profit (EBIT) | -39,1 | -55,5 | -41,9 |
Assets | 25,5 | 268,6 | 954,7 |
Net profit (loss) | -41,3 | -66,8 | -61,7 |
Cash | 0,6 | 4,5 | 632,3 |
Net income from sale | 277 | 329,4 | 18,9 |
Liabilities and provisions for liabilities | 61,7 | 371,6 | 501,8 |
Working assets | 25,5 | 37,6 | 47,6 |
Depreciation | 0 | 14,3 | -∞ |
% | % | p.p. | |
Profitability of capital | 113,8 | 64,8 | -49 |
Equity capital to total assets | -142,5 | -38,4 | 104,1 |
Gross profit margin | -14,9 | -20,3 | -5,4 |
EBITDA Margin | -14,1 | -12,5 | 1,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 63 | 182 | 119 |
Current financial liquidity indicator | 0.5313200354576111 | 0.22838212549686432 | -0,3 |
Net dept to EBITDA | -0.7835158109664917 | -7.3522467613220215 | -6,6 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Colep Polska
Kleszczów
MJ Chemicals Anna Kwiecińska
Pasłęk
PAWEŁ KUROWSKI UNIQUE
Wrocław
starlashstudio
Sydney
AtrasLac Patrycja Atras-Nowakowska
Żółkiewka-Osada
Medi- flos
Magdalena Sobieska
Warszawa